Mantle cell lymphoma with IRTA1+ reactive expansion of the marginal zone No … ← Chronic eosinophilic leukemia with a novel JAK1 mutation responds well to the JAK1/2 inhibitor ruxolitinib Mantle cell lymphoma with IRTA1+ reactive expansion of the marginal zone →